Journal Article DKFZ-2026-00249

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
A measles virus encoding a CD19/CD3 bispecific T cell engager shows enhanced preclinical anti-BCP-ALL efficacy without significant toxicity

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Elsevier [New York]

Molecular therapy. Oncology. 34(1), 201127 () [10.1016/j.omton.2026.201127]  GO


Contributing Institute(s):
  1. KKE Virotherapie (D490)
Research Program(s):
  1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2026
Database coverage:
OpenAccess
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database
Open Access

 Record created 2026-02-02, last modified 2026-04-23


Fulltext:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)